Ionis Pharmaceuticals
IONS
#2585
Rank
NZ$9.24 B
Marketcap
$58.53
Share price
-7.76%
Change (1 day)
-29.10%
Change (1 year)

Operating Margin for Ionis Pharmaceuticals (IONS)

Operating Margin as of November 2024 (TTM): -42.40%

According to Ionis Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -42.40%. At the end of 2023 the company had an Operating Margin of -42.40%.

Operating Margin history for Ionis Pharmaceuticals from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-42.40%-3.47%
2022-43.92%1121.25%
2021-3.60%-80.51%
2020-18.45%-161.14%
201930.18%-337.62%
2018-12.70%289.54%
2017-3.26%-78.85%
2016-15.42%-50.25%
2015-30.99%22%
2014-25.40%-43.8%
2013-45.19%-38.17%
2012-73.09%-14.59%
2011-85.57%51.77%
2010-56.38%115.84%
2009-26.12%92.86%
2008-13.55%-75.99%
2007-56.42%-87.25%
2006-442.52%253.62%
2005-125.14%-37.56%
2004-200.42%29.82%
2003-154.38%150.37%
2002-61.66%-28.75%
2001-86.54%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
26.89%-163.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-234,760.00% 553,579.25% Bahamas

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.